[Wagg & Purr] Atipamezole Injection

País: Australia

Idioma: inglés

Fuente: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes activos:

ATIPAMEZOLE HYDROCHLORIDE

Disponible desde:

AVET HEALTH LIMITED

Designación común internacional (DCI):

atipamezole HCl(5mg/mL)

formulario farmacéutico:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composición:

ATIPAMEZOLE HYDROCHLORIDE UNGROUPED Active 5.0 mg/ml

Unidades en paquete:

10mL

clase:

VM - Veterinary Medicine

Fabricado por:

MODERN VET THERAPEUT

Grupo terapéutico:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Área terapéutica:

ANTIDOTES

indicaciones terapéuticas:

MEDETOMIDINE REVERSING AGENT&ANTAGONIST

Resumen del producto:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; For parenteral use in reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats.Use in pregnant animals has not been established, and is therefore not recommended.

Estado de Autorización:

Registered

Fecha de autorización:

2023-07-01

Información para el usuario

Product Name:
Application No:
[Wagg & Purr] Atipamazole Injection
63527/129270
Label Name:
[Wagg & Purr] Atipamazole Injection
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
5 mg/m
L
ATIPAMEZOLE HYDROCHLORIDE
Claims:
[Short Claim]
Specific
reverser of medetomidine for dogs and cats.
[Long Claim]
For parenteral use in reversing and abolishing the effects of
medetomidine
hydrochloride in dogs and cats.
Net Contents:
10mL
Directions for Use:
Restraints:
Contraindications:
The use of [Wagg & Purr] Atipamezole Injection in pregnant animals has
not been
established and is therefore not recommended.
Precautions:
Due to the potent pharmacological activity of [Wagg & Purr]
Atipamezole Injection, skin
contact with atipamezole solution should be avoided. Wipe any spillage
off the skin of the
animal.
Side Effects:
In dogs, a transient hypotensive effect has been observed during the
first 10 minutes post-
injection. Vomiting and panting after [Wagg & Purr] Atipamezole
Injection have been
reported but these effects appear to be rare. Transient over-alertness
and tachycardia
may be observed after a possible overdose. RLP APPROVED
Dosage and
Administration:
Discard unused product within 6 months of first broaching the vial.
For intramuscular injection.
Species Dose Quantity
Dog I.M./ 5 x medetomidine dose (50-400 µg/kg) Same volume as the
medetomidine
dose Cat I.M./ 2.5 x medetomidine dose (125-375 µg/kg) Half the
volume of the
medetomidine dose
[Wagg & Purr] Atipamezole Injection is absorbed quickly and is
generally administered
15-60 minutes after medetomidine.
General Directions:
Description
A clear colourless solution for injection.
Indications
[Wagg & Purr] Atipamezole Injection
is a selective alpha -2 adrenergic receptor
antagonist which is capable of reversing and abolishing the effects of
medetomidine
hydrochloride in dogs and cats.
Withholding Periods:
Trade Advice:
Safety Directions:
First Aid Instructions:
If poisoning occurs, contact a doc